Community Group Learning Program to Prevent and Control Type 2 Diabetes in Rural Kabul
Tests a community group learning program for type 2 diabetes in rural Kabul.
Plain-language title generated from the registry record
Registry title: Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors
Key facts
- Where
- Kabul, AfghanistanSee the site
Where in Afghanistan
- HealthNet TPO, AfghanistanKabul, AfghanistanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- HealthNet Transcultural Psychosocial Organization
- Trial code
- NCT07350694
- Record updated
- 20 January 2026
- Original description
This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.Read full original descriptionShow less
Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D-Afg]: Feasibility Trial in Rural Kabul-Afghanistan
This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.
Inclusion: For intervention phase: Individuals aged 20 years and above. For baseline and endline assessments (before and after the intervention): Individuals aged 30 years and above; Participants residing in the randomized clusters of Kabul, Afghanistan Individuals willing to participate in the study and provide consent; All individuals with normoglycemia, intermediate hyperglycaemia, and diabetes are encouraged to participate; Participants who can attend the scheduled meetings and interventions as per the study protocol.
Exclusion: Participants with reported health conditions that may hinder their active involvement in the study; For Intervention phase: Individuals below the age of 20 years. For baseline and endline assessments (before and after the intervention): individuals below the age of 30 years; Individuals unwilling to provide consent for participation; Individuals with non-compliance with research protocols.